Stereotaxis Inc Stock OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
05-13 | Transcript : Stereotaxis, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Stereotaxis to Buy Access Point Technologies | MT |
Sales 2024 * | 29.5M 40.19M | Sales 2025 * | 44.25M 60.28M | Capitalization | 172M 234M |
---|---|---|---|---|---|
Net income 2024 * | -19M -25.88M | Net income 2025 * | -16M -21.8M | EV / Sales 2024 * | 5.82 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-8.89
x | P/E ratio 2025 * |
-11.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
David Fischel
CEO | Chief Executive Officer | 57 | 16-09-28 |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
David Fischel
CEO | Chief Executive Officer | 57 | 16-09-28 |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+2.13% | 64.85B | |
+18.24% | 54.33B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B |